Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

1st Jul 2008 17:54

RNS Number : 0811Y
Synergy Healthcare PLC
01 July 2008
 

 

1 July 2008

SYNERGY HEALTHCARE PLC ("the Company")

The Company has been notified that the following award of LTIP options have been made, pursuant to the LTIP scheme, to certain executive directors of the Company over 192,136 ordinary shares of 0.625p each in the Company ("Ordinary Shares"), as follows:

Director
Award
Share Price (p)
Richard Steeves (Chief Executive)
104,603
738.5
Ivan Jacques (Group Finance Director)
49,163
738.5
Marcello Smit (Chief Executive of Lips Textielservice)
38,370
738.5

In accordance with the LTIP scheme rules for conditional awards, the LTIP options were made based on a share price of 738.5 pence per Ordinary Share, being the closing price of an Ordinary Share as at 30 June 2008.

The LTIP options have been granted on a conditional basis and no shareholder rights will be conferred upon the grantee until the LTIP options have vested. Such vesting is subject to the achievement of the performance criteria of the scheme over the three year measurement period to 30 June 2011.

Furthermore, on 5 June 2008 Synergy Healthcare was notified that Dr Richard Steeves, Chief Executive and Mr Ivan Jacques, Group Finance Director, purchased 100,000 shares and 2,500 shares in the Company respectively. Both purchases were made at 710p per share.

Accordingly, on 30 June 2008 up to 59,420 and 5,000 matching shares were awarded under the LTIP Co-invest Options scheme to Dr Steeves and Mr Jacques respectively which will vest on 30 June 2011 subject to the terms of the scheme. The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-invest.

Enquiries

Ivan Jacques (Group Finance Director and Company Secretary) +44 (0) 1793 891 861

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSILFVRDLILIIT

Related Shares:

SYR.L
FTSE 100 Latest
Value8,473.05
Change9.59